Institutional

News about the Lipids, Nutrition and Cardiovascular Prevention Clinic

June 4 2018 | Appointment

All news

Yves Berthiaume, Vice President, Clinic and Clinical Research of the Montreal Clinical Research Institute (IRCM), is pleased to announce the appointment of Sophie Bernard as the Director of the Lipids, Nutrition and Cardiovascular Prevention Clinic at the Montreal Clinical Research Institute (IRCM) and Alexis Bass as Associate Director. This clinic was known in the past as the Nutrition, Metabolism and Atherosclerosis Clinic. 

This appointment follows the decision of Robert Dufour to, from now on, only to practise medicine. Dr. Dufour will be absent from the clinic for an undetermined period.

Dr. Berthiaume took this opportunity to “warmly thank Dr. Dufour, who is a clinical investigator at the IRCM since 1982, for nearly forty years of commitment to the Institute and for his constant dedication to his patients. As a specialist in the diagnosis and treatment of dyslipidemias, Dr. Dufour’s research was focused on the mechanisms associated with the regulation of plasma lipids and on new avenues to treat dyslipidemias. His work contributed to advancing research and to promote patients’ well-being. Dr. Dufour is one of the principal investigators of several recent clinical studies evaluating the effect of anti-PCSK9 in the treatment of hypercholesterolemia. As a leader in his field of expertise, this outstanding physician and remarkable humanist has trained a generation of doctors inspired by his approach. The management of the clinic will now be under the guidance of Drs. Sophie Bernard and Alexis Baass, both colleagues of Dr. Dufour.”

Lipids, Nutrition and Cardiovascular Prevention Clinic
Thanks to an outstanding team, to the knowledge of eminent clinical investigators and to their collaboration with the IRCM’s basic science researchers, the Lipids, Nutrition and Cardiovascular Prevention Clinic will continue to evaluate and treat cases of high cholesterol and other blood lipids as well as the risks of cardiovascular and metabolic diseases resulting from it. To better understand the origin of these lipid disorders and their complications, the Institute’s research team will continue studies on the nutritional, biochemical, genetic, molecular and pharmacological aspects of their causes in order to offer new and more effective treatments and reduce complications.

About Sophie Bernard
Physician and researcher, Sophie Bernard is a specialist in endocrinology and metabolic diseases. Dr. Sophie Bernard also practices medicine at the Centre hospitalier de l’Université de Montréal (CHUM) and she is an Assistant Professor in the Department of Medicine at the Faculty of Medicine of Université de Montréal. Dr. Bernard is the author and co-author of several scientific publications. She completed her medical degree at the University Claude Bernard-Lyon 1, in France, and obtained a specialization in endocrinology metabolism and nutrition as well as a PhD in biology of vascular diseases and a sub-specialization in lipid metabolism at the same university.

About Alexis Baass
Physician and researcher, Dr. Alexis Baass is a biochemist and a specialist in lipid diseases. Dr. Baass also practices medicine at McGill University Health Centre (MUHC). He is a member in the Department of Medical Biochemistry and an Assistant Professor at the McGill University’s Faculty of Medicine. He is also an associate member of the MUHC’s Department of Endocrinology and of the Department of Medical Biochemistry at the Centre hospitalier de l’Université de Montréal (CHUM). He completed his medical degree at Université de Montréal and obtained a specialization in medical biochemistry. He has also completed a master’s degree in experimental sciences as well as additional training in lipidology.